Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase.
In this study, we showed inflammation-promoted tumour progression was prevented by administration of a SOD derivative, oxykine.